PMID- 27339469
OWN - NLM
STAT- MEDLINE
DCOM- 20171116
LR  - 20220330
IS  - 1872-8332 (Electronic)
IS  - 0169-5002 (Linking)
VI  - 107
DP  - 2017 May
TI  - Possible applications of circulating tumor cells in patients with non small cell 
      lung cancer.
PG  - 59-64
LID - S0169-5002(16)30349-X [pii]
LID - 10.1016/j.lungcan.2016.05.027 [doi]
AB  - Recent experiences indicate that, as already reported for other types of cancer, 
      circulating tumor cells (CTCs) may play a role also in non small cell lung cancer 
      (NSCLC) for diagnosis, therapy monitoring and prognostic purposes. CTCs 
      evaluation could be particularly relevant in this clinical setting not only for 
      the objective difficulty in obtaining tumor tissue, but also because of the lack 
      of reliable tumor markers. In the current review, we will focus on the possible 
      applications of CTCs in NSCLC patients.
CI  - Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved.
FAU - Tartarone, Alfredo
AU  - Tartarone A
AD  - Department of Onco-Hematology, Division of Medical Oncology, Centro di 
      Riferimento Oncologico della Basilicata, IRCCS, Rionero in Vulture (PZ), Italy. 
      Electronic address: tarta1@virgilio.it.
FAU - Rossi, Elisabetta
AU  - Rossi E
AD  - Department of Surgery, Oncology and Gastroenterology, Oncology Section, 
      University of Padova, Padova, Italy.
FAU - Lerose, Rosa
AU  - Lerose R
AD  - Hospital Pharmacy, Centro di Riferimento Oncologico della Basilicata, IRCCS, 
      Rionero in Vulture (PZ), Italy.
FAU - Mambella, Giuseppina
AU  - Mambella G
AD  - Department of Onco-Hematology, Division of Medical Oncology, Centro di 
      Riferimento Oncologico della Basilicata, IRCCS, Rionero in Vulture (PZ), Italy.
FAU - Calderone, Giuseppe
AU  - Calderone G
AD  - Department of Onco-Hematology, Division of Medical Oncology, Centro di 
      Riferimento Oncologico della Basilicata, IRCCS, Rionero in Vulture (PZ), Italy.
FAU - Zamarchi, Rita
AU  - Zamarchi R
AD  - Istituto Oncologico Veneto IRCCS, Padova, Italy.
FAU - Aieta, Michele
AU  - Aieta M
AD  - Department of Onco-Hematology, Division of Medical Oncology, Centro di 
      Riferimento Oncologico della Basilicata, IRCCS, Rionero in Vulture (PZ), Italy.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160531
PL  - Ireland
TA  - Lung Cancer
JT  - Lung cancer (Amsterdam, Netherlands)
JID - 8800805
RN  - 0 (Biomarkers, Tumor)
RN  - EC 2.7.10.1 (ALK protein, human)
RN  - EC 2.7.10.1 (Anaplastic Lymphoma Kinase)
RN  - EC 2.7.10.1 (ErbB Receptors)
RN  - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases)
SB  - IM
MH  - Anaplastic Lymphoma Kinase
MH  - Biomarkers, Tumor/blood/*metabolism
MH  - Carcinoma, Non-Small-Cell Lung/blood/*pathology/therapy
MH  - Cell Count
MH  - Clinical Decision-Making
MH  - ErbB Receptors/genetics
MH  - Humans
MH  - Liquid Biopsy
MH  - Lung Neoplasms/blood/*pathology
MH  - Mutation
MH  - Neoplastic Cells, Circulating/metabolism/*pathology
MH  - Prognosis
MH  - Receptor Protein-Tyrosine Kinases
OTO - NOTNLM
OT  - Anaplastic lymphoma kinase fusion gene
OT  - Circulating tumor cells
OT  - Epidermal growth factor receptor
OT  - Liquid biopsy
OT  - Non small cell lung cancer
EDAT- 2016/06/25 06:00
MHDA- 2017/11/29 06:00
CRDT- 2016/06/25 06:00
PHST- 2016/03/01 00:00 [received]
PHST- 2016/05/01 00:00 [revised]
PHST- 2016/05/29 00:00 [accepted]
PHST- 2016/06/25 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2016/06/25 06:00 [entrez]
AID - S0169-5002(16)30349-X [pii]
AID - 10.1016/j.lungcan.2016.05.027 [doi]
PST - ppublish
SO  - Lung Cancer. 2017 May;107:59-64. doi: 10.1016/j.lungcan.2016.05.027. Epub 2016 
      May 31.